Skip to main content

Table 1 patient characteristics.

From: Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the IL28B gene

  Cross-sectional study Longitudinal study
Number of patients 84 56
Sex: male 76 (90%) 51(91%)
Age (median, range) 43 (24 - 70) 41 (24 - 62)
Rise factor   
Haemophilia 56 (67%) 35 (63%)
i. v. drugs 22 (26%) 16(29%)
man who have sex with man 6 (7%) 5 (9%)
HCV-RNA negative 14(17%) 5 (9%)
HCV viral load > 800000 1 U/1 55 (66%) 39 (70%)
HCV-Genotype   
1 52 (62%) 39 (72%)
2 6(7%) 3 (6%)
3 13(16%) 10(19%)
4 4 (5%) 2 (4%)
HAART 67 (82%) 46 (84%)
PI-based HAART 50 (75%) 37 (80%)
NNRTI-based HAART 17 (25%) 9 (20%)
< 50 HIV copies/ml 62 (74%) 43 (77%)
CD4-Count (median, range) [cell/μl 397 (10 - 1757) 394 (10 - 966)
AST (median, range) [U/l] 47 (21 - 197) 48 (21 - 197)
ALT (median, range) [U/l] 72 (8 - 275) 77 (16 - 275)
Platelets (median, range) [T/l] 160 (9 - 337) 148 (9 - 325)
Stiffness (median, range) [kPa] 7.4 (3.3 - 48) 7.8 (3.3 - 48)
APRI (median, range) n = 75 n = 52
  0.9 (0.3 - 43.2) 11.1 (0.4 - 43.2)
FIB-4 (median, range) n = 75 n = 52
  11.6 (0.5 - 50.3) 11.6 (0.5 - 50.3)
IL28B genotype:   
CC 42 (50%) 26 (46%)
CT 36 (43%) 25 (45%)
TT 6(7%) 5 (9%)
Time of follow-up (median, range) [months] 25 (5 - 50)